7459 — Medipal Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual income statement for Medipal Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,181,928	3,253,079	3,211,125	3,290,921	3,360,008
Cost of Revenue
Gross Profit	232,495	236,697	214,213	217,445	224,305
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,132,308	3,202,030	3,187,304	3,250,430	3,318,994
Operating Profit	49,620	51,049	23,821	40,491	41,014
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	63,461	75,536	49,237	57,284	70,061
Provision for Income Taxes
Net Income After Taxes	45,426	51,230	33,616	39,197	48,323
Minority Interest
Net Income Before Extraordinary Items
Net Income	34,360	37,970	23,927	29,425	38,806
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	34,256	37,865	23,823	29,320	38,752
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	149	147	152	148	206
Dividends per Share